Anastrozole Tablets 28mg Factory wholesale
$2.00
Anastrozole (brand: Yishuzhi®) is a potent third-generation non-steroidal aromatase inhibitor used primarily in research focused on estrogen-dependent breast cancer and hormone-related pathways. Each box contains 28 film-coated tablets (1?mg each). Manufactured by Zhejiang Hisun Pharmaceutical Co., Ltd., approved under China NMPA H20133110 (product code 86904641003065; barcode 6939030230917).
?? For laboratory research use only.?Please consult the staff for other purposes?
描述
Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Anastrozole Tablets (Yishuzhi®) |
| Generic Name | Anastrozole |
| CAS Number | 120511?73?1 :contentReference[oaicite:5]{index=5} |
| Molecular Formula | C??H??N? :contentReference[oaicite:6]{index=6} |
| Molecular Weight | 293.37?g/mol :contentReference[oaicite:7]{index=7} |
| Dosage Form | Film-coated oral tablet |
| Strength | 1?mg per tablet |
| Pack Size | 28 tablets per box |
| Approval Number | H20133110 (China NMPA) |
| Product Code | 86904641003065 |
| Manufacturer | Zhejiang Hisun Pharmaceutical Co., Ltd. |
| Barcode | 6939030230917 |
| Storage | Store at room temperature; protect from moisture |
| Intended Use | Laboratory research only |
Mechanism of Action
Anastrozole reversibly inhibits aromatase (CYP19), blocking conversion of androgens to estrogens, resulting in ?96% aromatase inhibition at 1?mg/day and an ~85% reduction in circulating estradiol news.qq.com+14en.wikipedia.org+14go.drugbank.com+14.
Research Applications & Pharmacology
-
Breast cancer research: hormone-dependent growth, estrogen receptor modulation
-
Endocrine pathway studies: estrogen synthesis, aromatase activity assays
-
Pharmacokinetics: Protein binding ~40%, hepatic metabolism (~85%), t½ 40–50?hrs, renal excretion <11%
Safety Profile & Common Adverse Effects
-
Clinical observations: hot flashes, fatigue, joint pain, nausea, headache, bone mineral density loss, mood disturbances, elevated liver enzymes
-
Handling notes: wear PPE, store tablets properly, report signs of hormonal modulation in animal models
-
Contraindications: not for pregnancy, premenopausal uterine bleeding, severe hepatic/renal impairment
?? Research?Use Disclaimer
This product is exclusively for laboratory research use and is not approved for therapeutic, diagnostic, clinical, or veterinary use. Misuse may pose safety risks and invalidate research findings.
其他信息
| 重量 | 1.1 公斤 |
|---|---|
| 尺寸 | 18 × 16 × 18 厘米 |
相关产品
-
Limertinib Tablets 80?mg ×?20 – by Osscon Pharma | Research Use Only (3rd?Gen EGFR?TKI)
Limertinib (OuyiXin®) is a third-generation EGFR tyrosine kinase inhibitor (EGFR?TKI) at 80?mg per tablet, 20 tablets per box, from Jiangsu Osscon Pharmaceutical. Approved by China’s NMPA under H20250004, it targets EGFR T790M?mutated non?small cell lung cancer, including patients with brain metastases.
?? For research use only – Not for human consumption or therapeutic use. $1.00 -
Pamidronate Disodium Injection 15?mg × 10 Vials Price comparison
High-purity Pamidronate Disodium 15?mg injectable solution, 10 vials per box. Manufactured by Chengdu Tiantai Shan Pharmaceutical Co., Ltd., it’s a nitrogen-containing bisphosphonate ideal for bone metabolism, osteoporosis, and oncology research.
?? For laboratory research purposes only – Not for human consumption or therapeutic use. $1.00 -
Reduced Glutathione Injection 0.6?g × 10 Vials – Ruiyang | Price comparison
Ruiyang Reduced Glutathione Injection (0.6?g per vial × 10) by Ruiyang Pharmaceutical Co., Ltd. Ideal for antioxidant, detoxification, and hepatic-protection research in metabolic and oxidative stress studies.
?? For laboratory research use only – Not for human consumption or therapeutic use. $2.00 -
Clodronate Disodium Capsules (Baiyunshan/Dewei) – 0.4?g × 10 Capsules Price comparison
Clodronate Disodium Capsules are a bisphosphonate medication used to inhibit osteoclast-mediated bone resorption. Manufactured by Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. and approved by China’s NMPA (National Medical Products Administration) under approval number H19980041. ?? Disclaimer:
This product is provided strictly for laboratory research and development use only. Not intended for human or veterinary use. Not for clinical, diagnostic, or therapeutic applications. $2.00
评价
目前还没有评价